---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-068092"
form_type: "8-K"
ticker: null
cik: "0000786947"
company_name: "ACURA PHARMACEUTICALS, INC"
filed_at: "2024-06-04T23:59:59+00:00"
generated_at: "2026-06-01T06:39:35.074492+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Acura Pharmaceuticals CFO Peter Clemens to retire effective Sept 30; Robert Seiser appointed successor

## Summary
- Peter Clemens steps down as CFO on July 31, 2024, remains VP through Sept 30 for transition.
- Robert A. Seiser, currently VP Treasurer & Corporate Controller since 1998, appointed Sr. VP & CFO effective Aug 1, 2024.
- Board approved Clemens's retirement and Seiser's appointment on May 31, 2024.
- Clemens will continue as Vice President until end of September to ensure smooth handover.

## SEC filing metadata
- accession: 0001104659-24-068092
- form_type: 8-K
- cik: 0000786947
- company_name: ACURA PHARMACEUTICALS, INC
- filed_at: 2024-06-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/786947/000110465924068092/0001104659-24-068092-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/786947/000110465924068092/tm2416319d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-068092
- JSON: https://secwatch.observer/filing/0001104659-24-068092.json
- Plain text: https://secwatch.observer/filing/0001104659-24-068092.txt

## Key facts
- Executive change
  Robert A. Seiser was appointed as Sr. Vice President and Chief Financial Officer at ACURA PHARMACEUTICALS, INC.
  - Action: appointed
  - Role: Sr. Vice President and Chief Financial Officer
  source text: Also on May 31, 2024, Robert A. Seiser was appointed as Sr. Vice President and Chief Financial Officer, effective August 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/786947/000110465924068092/0001104659-24-068092-index.htm
- Executive change
  Peter A. Clemens retired as Sr. Vice President and Chief Financial Officer at ACURA PHARMACEUTICALS, INC.
  - Action: retired
  - Role: Sr. Vice President and Chief Financial Officer
  source text: Although Mr. Clemens will remain an employee of the Company as Vice President until the end of September to ensure a smooth transition, he is stepping down as Chief Financial Officer, effective July 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/786947/000110465924068092/0001104659-24-068092-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.